Clinico-laboratory spectrum of dengue fever and predictors of severe dengue infection: a study from a tertiary care hospital in Mumbai

Manoj Vedpathak; Sachee Agrawal; Shweta Kawankar; Dileep Asgaonkar; Jayanthi Shastri

doi:10.18203/2320-6012.ijrms20263270

Authors

Manoj Vedpathak Department of Microbiology, Dr Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India https://orcid.org/0000-0003-2631-326X
Sachee Agrawal Department of Microbiology, Topiwala National Medical College, Mumbai, Maharashtra, India
Shweta Kawankar Department of Microbiology, Topiwala National Medical College, Mumbai, Maharashtra, India
Dileep Asgaonkar epartment of Medicine, Topiwala National Medical College, Mumbai, Maharashtra, India
Jayanthi Shastri Department of Microbiology, Topiwala National Medical College, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263270

Keywords:

Dengue, Severe dengue, Predictors of severity, Dengue criteria

Abstract

Background: Dengue is a rapidly spreading arboviral infection that can progress from flu-like illness to life-threatening severe forms. Since early prediction of severity is difficult, identifying clinical and laboratory predictors is essential for proper management.

Methods: A total 200 patients of either gender and of age ≥18 years with confirmatory diagnosis of dengue fever by dengue NS1 ELISA and/or RT-PCR were enrolled in this study from August 2017 to November 2018. Detailed clinical history was documented.

Results: Of 200 patients, 89% had non-severe (group A) and 11% had severe (group B). Common age group affected in both the groups were 18-30 years. In non-severe dengue, 7.3% patients presented with signs of bleeding as compared to 63.6% in severe dengue. Signs of plasma leakage were only seen in severe dengue (68.2%). Hepatomegaly was predominantly associated with severe dengue (90.9%) as compared to non-severe dengue (10.1%). Splenomegaly was noted from 31.8% patients with severe dengue as compared to only 1.7% patients with non-severe dengue. Secondary dengue infection was present in 2.2% of non-severe cases and 18.2% of severe cases. All patients with severe dengue had significantly higher viral load (≥1000 copies/ml) as compared to 78.7% patients with non-severe dengue.

Conclusions: The possible predictors of severe dengue may include young age with symptoms like rash, vomiting, lethargy and dyspnoea having signs of bleeding, plasma leakage and organomegaly. In addition, laboratory findings supporting severity are secondary infection, high viral load, thrombocytopenia, high haematocrit, raised liver enzymes and increased serum creatinine.

References

World Health Organization, Special Programme for Research, Training in Tropical Diseases. Dengue guidelines for diagnosis, treatment, prevention and control. 2009. Available at: https://www.who.int/ publications/i/item/9789241547871. Accessed on 15 May 2026.

Bandyopadhyay B, Bhattacharyya I, Adhikary S, Konar J, Dawar N, Sarkar J, et al. A comprehensive study on the 2012 dengue fever outbreak in Kolkata, India. ISRN Virol. 2013;3.

Cecilia D. Current status of dengue and chikungunya in India. WHO South-East Asia J Public Health. 2014;3(1):22.

Mallhi TH, Khan AH, Adnan AS, Sarriff A, Khan YH, Jummaat F. Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study. BMC Infect Dis. 2015;15(1):399.

Chakravarti A, Kumaria R. Eco-epidemiological analysis of dengue infection during an outbreak of dengue fever, India. Virol J. 2005;2(1):32.

Gupta E, Ballani N. Current perspectives on the spread of dengue in India. Infect Drug Resistance. 2014;7:337.

Gupta N, Srivastava S, Jain A, Chaturvedi U. Dengue in India. Indian Med Res. 2012;136(3):373.

Thomas L, Verlaeten O, Cabié A, Kaidomar S, Moravie V, Martial J, et al. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 coepidemic. Am J Trop Med Hygiene. 2008;78(6):990-8.

Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS One Negl Trop Dis. 2010;4(3):e617.

Yung CF, Lee KS, Thein TL, Tan LK, Gan VC, Wong JG, et al. Dengue serotype specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, Singapore.The Am J Trop Med Hygiene. 2015;92(5):999-1005.

Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003;305(2):330-8.

Jain S, Mittal A, Sharma SK, Upadhyay AD, Pandey RM, Sinha S, et al. Predictors of dengue-related mortality and disease severity in a tertiary care center in North India. Open Forum Infect Dis. 2017;4(2):ofx056.

Ho TS, Wang SM, Lin YS, Liu CC. Clinical and laboratory predictive markers for acute dengue infection. J Biomed Sci. 2013;20(1):75.

Bhushan D, Kumar R. Clinical Profile, Hepatic Dysfunctions, and Outcome of Dengue Patients in a Tertiary Care Hospital of Eastern India. J Assoc Phys India. 2018;66:47.

Tewari K, Tewari VV, Mehta R. Clinical and hematological profile of patients with dengue fever at a tertiary care hospital–an observational study. Mediterr J Hematol Infect Dis. 2018;10(1):e2018021.

Subbalaxmi MV, Kumar GV, Ramanjaneyulu KH, Kapoor A, Teja VD, Lakshmi V. Clinical, laboratory profile and outcome of dengue fever at a south Indian tertiary care hospital. J Clin Sci Res. 2017;6(3):160.

Wijeratne DT, Fernando S, Gomes L, Jeewandara C, Ginneliya A, Samarasekara S, et al. Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection. PLoS Negl Trop Dis. 2018;12(10):e0006540.

Temprasertrudee S, Thanachartwet V, Desakorn V, Keatkla J, Chantratita W, Kiertiburanakul S. A multicenter study of clinical presentations and predictive factors for severe manifestation of dengue in adults. Japan J Infect Dis. 2018;71(3):239-43.

Laul A, Laul P, Merugumala V, Pathak R, Miglani U, Saxena P. Clinical Profiles of Dengue Infection during an Outbreak in Northern India. J Trop Med. 2016;2016:5917934.

Kumar CM, Vyas KK, Krishna YS. Clinical profile of dengue fever with severe thrombocytopenia and its complications: a retrospective study at a tertiary care hospital in South India. Int J Res Med Sci. 2017;5(5):1751-5.

Low JG, Ong A, Tan LK, Chaterji S, Chow A, Lim WY, et al. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis. 2011;5(5):e1191.

Murugananthan K, Kandasamy M, Rajeshkannan N, Noordeen F. Demographic and clinical features of suspected dengue anddengue haemorrhagic fever in the Northern Province of Sri Lanka, a region afflicted by an internal conflict for more than 30 years—a retrospective analysis. Int J Infect Dis. 2014;27:32-6.

Karoli R, Fatima J, Siddiqi Z, Kazmi KI, Sultania AR. Clinical profile of dengue infection at a teaching hospital in North India. J Infect Develop Count. 2011;6(07):551-4.

Shu PY, Yang CF, Kao JF, Su CL, Chang SF, Lin CC, et al. Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports. Clin Vaccine Immunol. 2009;16(4):589-91.

Gajera VV, Sahu S, Dhar R. Study of haematological profile of dengue fever and its clinical implication. Ann Appl Bio-Sci. 2016;3(3):A241-6.

Srinivas G, Rao YR. Study of clinical and laboratory profile in patients of fever with thrombocytopenia and its outcome during hospital stay-a study at RIMS, a tertiary care hospital at Ongole, Prakasam district of Andhra Pradesh. J Evol Med Dent Sci. 2018;7(27):3092-6.

Gurugama P, Jayarajah U, Wanigasuriya K, Wijewickrema A, Perera J, Seneviratne SL. Renal manifestations of dengue virus infections. J Clin Virol. 2018;101:1-6.

Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181(1):2-9.

Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480-96.

Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. Viraemia in patients with naturally acquired dengue infection. Bull World Health Organiz. 1981;59(4):623.

Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the durationand magnitude of viraemia in children hospitalised during the 1996–1997dengue ‐2 outbreak in French Polynesia. J Med Virol. 2000;60(4):432-8.